Previous Article | Next Article ![]()
Eukaryotic Cell, May 2005, p. 879-889, Vol. 4, No. 5
1535-9778/05/$08.00+0 doi:10.1128/EC.4.5.879-889.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.
Constance Mehlgarten,1,
Hiroko K. Kitamoto,2,
Junko Nagase,2
Daniel Jablonowski,1
Robert C. Dickson,3
Michael J. R. Stark,4 and
Raffael Schaffrath1*
Biologicum, Institut für Genetik, Martin-Luther-Universität Halle-Wittenberg, Weinbergweg 10, D-06120 Halle (Saale), Germany,1 National Institute of Agrobiological Sciences, 2-1-2 Kannondai, Tsukuba, Ibaraki 305-8602, Japan,2 Department of Molecular and Cellular Biochemistry, University of Kentucky, College of Medicine, 800 Rose Street, Lexington, Kentucky,3 Division of Gene Regulation and Expression, School of Life Sciences, University of Dundee, MSI/WTB Complex, Dow Street, Dundee DD1 5EH, United Kingdom4
Received 25 January 2005/ Accepted 7 March 2005
Kluyveromyces lactis zymocin, a trimeric (
ß
) protein toxin complex, inhibits proliferation of Saccharomyces cerevisiae cells. Here we present an analysis of kti6 mutants, which resist exogenous zymocin but are sensitive to intracellular expression of its inhibitory
-toxin subunit, suggesting that KTI6 encodes a factor needed for toxin entry into the cell. Consistent with altered cell surface properties, kti6 cells resist hygromycin B, syringomycin E, and nystatin, antibiotics that require intact membrane potentials or provoke membrane disruption. KTI6 is allelic to IPT1, coding for mannosyl-diinositolphospho-ceramide [M(IP)2C] synthase, which produces M(IP)2C, the major plasma membrane sphingolipid. kti6 membranes lack M(IP)2C and sphingolipid mutants that have reduced levels of M(IP)2C precursors, including the sphingolipid building block ceramide survive zymocin. In addition, kti6/ipt1 cells allow zymocin docking but prevent import of its toxic
-subunit. Genetic analysis indicates that Kti6 is likely to act upstream of lipid raft proton pump Kti10/Pma1, a previously identified zymocin sensitivity factor. In sum, M(IP)2C operates in a plasma membrane step that follows recognition of cell wall chitin by zymocin but precedes the involvement of elongator, the potential toxin target.
These authors contributed equally to the work.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»